CTSO: CytoSorbents provides a regulatory update for DrugSorb-ATR.
CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...
203 Views
CTSO: CytoSorbents reports 4th quarter and 2024 financial results which showed impressive product revenue growth that was above our expectations.
CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...
411 Views
CTSO: CytoSorbents reports 4th quarter and 2024 financial results which showed impressive product revenue growth that was above our expectations.
CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...
357 Views
CTSO: CytoSorbents reports 4th quarter and 2024 financial results which showed impressive product revenue growth that was above our expectations.
CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...
370 Views
CTSO: CytoSorbents reports 4th quarter and 2024 financial results which showed impressive product revenue growth that was above our expectations.
CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...
364 Views